Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report
We report on a 12-month-old girl with an ectopic atrial tachycardia successfully treated with the combination of a beta blocking agent and Ivabradine that acts on cardiac pacemaker cells by selectively inhibiting the If channel. Standard therapy had failed to control the tachycardia before. No side...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2020.00313/full |
id |
doaj-6ab15c9a69504c7ab3b269f603edff5c |
---|---|
record_format |
Article |
spelling |
doaj-6ab15c9a69504c7ab3b269f603edff5c2020-11-25T02:27:26ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602020-06-01810.3389/fped.2020.00313503086Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case ReportHolger Michel0Frank Heißenhuber1Sven Wellmann2Michael Melter3Stephan Gerling4University Children's Hospital Regensburg (KUNO), University of Regensburg, Regensburg, GermanyClinic for Cardiology-Electrophysiology, Hospital Barmherzige Brüder, Regensburg, GermanyUniversity Children's Hospital Regensburg (KUNO), University of Regensburg, Regensburg, GermanyUniversity Children's Hospital Regensburg (KUNO), University of Regensburg, Regensburg, GermanyUniversity Children's Hospital Regensburg (KUNO), University of Regensburg, Regensburg, GermanyWe report on a 12-month-old girl with an ectopic atrial tachycardia successfully treated with the combination of a beta blocking agent and Ivabradine that acts on cardiac pacemaker cells by selectively inhibiting the If channel. Standard therapy had failed to control the tachycardia before. No side effects attributable to Ivabradine were noticed. Due to its mechanism of action Ivabradine is a promising novel agent for the therapy of tachycardia due to increased automaticity. Reports on the use of Ivabradine in young children or infants are rare, but show promising results for congenital junctional ectopic tachycardia. This report adds the second case of ectopic atrial tachycardia in this age group and novel treatment with Ivabradine to the literature.https://www.frontiersin.org/article/10.3389/fped.2020.00313/fulltachycardiaatrialIvabradinebeta-blockerchildrencase report |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Holger Michel Frank Heißenhuber Sven Wellmann Michael Melter Stephan Gerling |
spellingShingle |
Holger Michel Frank Heißenhuber Sven Wellmann Michael Melter Stephan Gerling Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report Frontiers in Pediatrics tachycardia atrial Ivabradine beta-blocker children case report |
author_facet |
Holger Michel Frank Heißenhuber Sven Wellmann Michael Melter Stephan Gerling |
author_sort |
Holger Michel |
title |
Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report |
title_short |
Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report |
title_full |
Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report |
title_fullStr |
Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report |
title_full_unstemmed |
Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report |
title_sort |
ectopic atrial tachycardia in a 12-month-old girl treated with ivabradine and beta-blocker, a case report |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pediatrics |
issn |
2296-2360 |
publishDate |
2020-06-01 |
description |
We report on a 12-month-old girl with an ectopic atrial tachycardia successfully treated with the combination of a beta blocking agent and Ivabradine that acts on cardiac pacemaker cells by selectively inhibiting the If channel. Standard therapy had failed to control the tachycardia before. No side effects attributable to Ivabradine were noticed. Due to its mechanism of action Ivabradine is a promising novel agent for the therapy of tachycardia due to increased automaticity. Reports on the use of Ivabradine in young children or infants are rare, but show promising results for congenital junctional ectopic tachycardia. This report adds the second case of ectopic atrial tachycardia in this age group and novel treatment with Ivabradine to the literature. |
topic |
tachycardia atrial Ivabradine beta-blocker children case report |
url |
https://www.frontiersin.org/article/10.3389/fped.2020.00313/full |
work_keys_str_mv |
AT holgermichel ectopicatrialtachycardiaina12montholdgirltreatedwithivabradineandbetablockeracasereport AT frankheißenhuber ectopicatrialtachycardiaina12montholdgirltreatedwithivabradineandbetablockeracasereport AT svenwellmann ectopicatrialtachycardiaina12montholdgirltreatedwithivabradineandbetablockeracasereport AT michaelmelter ectopicatrialtachycardiaina12montholdgirltreatedwithivabradineandbetablockeracasereport AT stephangerling ectopicatrialtachycardiaina12montholdgirltreatedwithivabradineandbetablockeracasereport |
_version_ |
1724843181138247680 |